Both transporters are implicated in disease, since genetic mutations in ATP13A2 have been linked to neurodegeneration, whereas ATP13A3 is genetically implicated in pulmonary arterial hypertension and may play a role in cancer (see [14] and references therein). The gene discussed is ATP13A3; the disease is pulmonary arterial hypertension.